Venatorx Pharmaceuticals Names Scott McConnell, Pharm.D. as Vice President, Medical Affairs

By WebmasterDecember 2, 2021November 1st, 2024No Comments

Venatorx Pharmaceuticals Names Scott McConnell, Pharm.D. as Vice President, Medical Affairs

Previous PostAllianceChicago to Offer Wellsheet’s Predictive Clinical Workflow Platform Integrated with athenahealth’s EHR
Next PostImmunome Announces Submission of an Investigational New Drug (IND) Application for IMM-BCP-01 for the Treatment of COVID-19